China Biologic Products Holdings Inc (CBPO) Return on Equity ROE from the fourth quarter 2019 to fourth quarter 2018 and annually, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Biologic Products Holdings Inc   (NASDAQ: CBPO)

China Biologic Products Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for China Biologic Products Holdings Inc in the fourth quarter 2019?
China Biologic Products Holdings Inc achieved a return on average equity (ROE) of 9.31 % in its fourth quarter 2019, which is below China Biologic Products Holdings Inc 's average return on equity, which stands at 28.82%.

ROE has advanced compared to 8.4% in the third quarter 2019, due to net income growth.

Within the Biotechnology & Pharmaceuticals industry 8 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2019 from 0 to 1753.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Equity Change -1.53 % -3.79 % -3.79 % -3.79 % -
Y / Y Net Income Change 10.43 % - - - 79.93 %
Net Income (TTM) in Millions 163 148 148 148 148
Return On Equity (TTM) 9.31 % 8.4 % 8.32 % 8.24 % 8.16 %
CBPO's Total Ranking # 1753 # 0 # 0 # 0 # 1821
Equity (TTM) in Millions 1,696 1,775 1,775 1,775 1,722
Seq. Equity Change -4.46 % 0 % 0 % 3.07 % -6.65 %
Seq. Net Income Change - - - - -

Back to CBPO Management Effectiveness >> CBPO's 5 Years Annual ROE >> Compare CBPO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 9
Sector # 141
Overall # 1753

Return On Equity Statistics
High Average Low
44.55 %
28.82 %
8.59 %
(Mar 31 2015)   (Dec 31 2018)





CBPO Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Equity in Millions 1,696 1,722 664 521 467
Y / Y Equity Change -1.53 % 159.22 % 27.48 % 11.6 % 69.64 %
Net Income in Millions 163 148 82 129 114
Y / Y Net Income Change 10.43 % 79.93 % -36.15 % 12.87 % 18.72 %
Return On Equity 9.64 % 8.59 % 12.38 % 24.71 % 24.44 %

Back to CBPO Management Effectiveness >> CBPO's 5 Years Annual ROE >> Compare CBPO ROE to its Competitors




Annual Roe Comment
In 2019 ROE improved to 9.64 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CBPO's' Return on Equity at Yahoo Finance
CBPO's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CBPO's Competitors
Subscribers only: Roe for China Biologic Products Holdings Inc 's Suppliers
Subscribers only: Return On Equity for CBPO's Customers




Companies with similar Return On Equity at Dec 31 2019, within Healthcare Sector ROE
Johnson and Johnson  25.47 %
Abiomed Inc   24.65 %
U S Physical Therapy Inc  24.60 %
Gilead Sciences Inc   24.32 %
Arrowhead Pharmaceuticals Inc   23.30 %
Icon Plc  23.23 %
Alexion Pharmaceuticals Inc   23.17 %
Pro dex Inc   22.99 %
Illumina Inc   22.69 %
Pra Health Sciences Inc   22.53 %
Vertex Pharmaceuticals Inc  22.28 %
Bruker Corporation  22.23 %
Resmed Inc   21.97 %
Amedisys Inc  21.97 %
Gsk Plc  21.63 %
Fonar Corporation  21.61 %
Biospecifics Technologies Corp  21.56 %
Select Medical Holdings Corp  21.41 %
Novartis Ag  21.13 %
Supernus Pharmaceuticals inc   20.98 %
Exelixis Inc   20.83 %
Akorn Inc  20.79 %
Regeneron Pharmaceuticals Inc   20.75 %
Ionis Pharmaceuticals Inc   20.49 %
Viemed Healthcare Inc   20.34 %
Alpha Pro Tech Ltd   20.22 %
Henry Schein Inc   20.13 %
Msa Safety Inc  19.70 %
Iradimed Corporation  19.35 %
Incyte Corporation  19.11 %

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.